User profiles for D. Kempf

DeAnna Kempf

- Verified email at mtsu.edu - Cited by 2067

Dominic Kempf

- Verified email at iwr.uni-heidelberg.de - Cited by 297

[HTML][HTML] The Dune framework: Basic concepts and recent developments

…, R Fritze, C Gräser, C Grüninger, D Kempf… - … & Mathematics with …, 2021 - Elsevier
… a d -dimensional grid the highest dimension of any entity is d … E c of codimension 0 ≤ c
d . Entities of each set E c are … In particular we call E d the set of vertices, E d − 1 the set of …

Ordered accumulation of mutations in HIV protease confers resistance to ritonavir

…, CAB Boucher, JM Leonard, DW Norbeck, DJ Kempf - Nature medicine, 1996 - nature.com
Abstract Analysis of the HIV protease gene from the plasma of HIV–infected patients
revealed substitutions at nine different codons selected in response to monotherapy with the …

Design, Activity, and 2.8 Å Crystal Structure of a C2 Symmetric Inhibitor Complexed to HIV-1 Protease

J Erickson, DJ Neidhart, J VanDrie, DJ Kempf… - Science, 1990 - science.org
… In the modeling experiment, the structure ofthe reduced peptide inhibitor D-HisPro-Phe-His-Phe-4[CH2-NH]
- Phe-Val-Tyr, derived from … DJ Kempf, in preparation. 29. DA Paul et al., J. …

A controlled trial to improve care for seriously iII hospitalized patients: The study to understand prognoses and preferences for outcomes and risks of treatments …

…, M Folien, P Mowery, BE Backus, DL Kempf… - Jama, 1995 - jamanetwork.com
Objectives. —To improve end-of-life decision making and reduce the frequency of a mechanically
supported, painful, and prolonged process of dying. Design. —A 2-year prospective …

Consumer processing of product trial and the influence of prior advertising: A structural modeling approach

DS Kempf, RE Smith - Journal of Marketing Research, 1998 - journals.sagepub.com
A major goal of this study is to develop and test a structural model of trial processing to help
marketers and researchers better understand the dynamics of this important stage in the …

ABT-378, a highly potent inhibitor of the human immunodeficiency virus protease

HL Sham, DJ Kempf, A Molla, KC Marsh… - Antimicrobial agents …, 1998 - Am Soc Microbiol
… A high (>10 5 -fold) specificity for HIV protease over those of the mammalian aspartic
proteinases renin, cathepsin D, and cathepsin E was observed (data not shown). In MT4 cells, the …

ABT-538 is a potent inhibitor of human immunodeficiency virus protease and has high oral bioavailability in humans.

DJ Kempf, KC Marsh, JF Denissen… - Proceedings of the …, 1995 - National Acad Sciences
… In contrast, ABT-538 inhibited human cathepsins D and E with Ki values of 20 nM and 8
nM, respectively (J. Kay, personal communication). Nonetheless, these values still represent a …

Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy

…, GJ Hanna, SC Brun, DJ Kempf… - Proceedings of the …, 2008 - National Acad Sciences
Residual viremia can be detected in most HIV-1-infected patients on antiretroviral therapy
despite suppression of plasma RNA to <50 copies per ml, but the source and duration of this …

Pharmacokinetic enhancement of inhibitors of the human immunodeficiency virus protease by coadministration with ritonavir

DJ Kempf, KC Marsh, G Kumar… - Antimicrobial agents …, 1997 - Am Soc Microbiol
… Details of the syntheses can be obtained from DJ Kempf. All synthetic analogs were
characterized by nuclear magnetic resonance and mass spectral analysis and were shown to be of …

Attitude formation from product trial: Distinct roles of cognition and affect for hedonic and functional products

DAS Kempf - Psychology & marketing, 1999 - Wiley Online Library
Affective and cognitive responses to a product trial are examined in an experiment containing
two cells representing two product types: hedonic and functional. The stimulus products …